KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
Korro Bio (KRRO) announced that the U.S. Food and Drug Administration has granted orphan drug designation, ODD, to the investigational medicine ...
The General Services Administration, working with Elon Musk's Department of Government Efficiency, has notified landlords ...
Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...
The U.S. Food and Drug Administration on Thursday made recommendations to vaccine manufacturers for the virus strains to be ...
In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...
Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...
The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain ...
University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to repair the lungs, helping explain the lingering effects of long COVID.
For most children, symptoms may be controlled by avoiding the allergen, if known, and using nonprescription medicines. But if a child's symptoms are persistent and not relieved by nonprescription ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback